Select Publications

PREVIOUS PAGE
Aug 2020
Application of a Combined Aggregate Exposure Pathway and Adverse Outcome Pathway (AEP-AOP) Approach to Inform a Cumulative Risk Assessment: A Case Study with Phthalates
VIEW ABSTRACT
Apr 2020
Identifying Qualitative Differences in PPARα Signaling Networks in Human and Rat Hepatocytes and Their Significance for Next Generation Chemical Risk Assessment Methods
VIEW ABSTRACT
Jan 2020
The Role of Fit-For-Purpose Assays Within Tiered Testing Approaches
VIEW ABSTRACT
Sep 2019
Workshop on the Validation and Regulatory Acceptance of Innovative 3R Approaches in Regulatory Toxicology
VIEW ABSTRACT
Aug 2019
Addressing Systematic Inconsistencies Between in Vitro and in Vivo Transcriptomic Mode of Action Signatures
VIEW ABSTRACT
Apr 2019
An Evaluation of the USEPA Proposed Approaches for Applying a Biologically Based Dose-Response Model in a Risk Assessment for Perchlorate in Drinking Water
VIEW ABSTRACT
Mar 2019
Dose-dependence of Chemical Carcinogenicity: Biological Mechanisms for Thresholds and Implications for Risk Assessment
VIEW ABSTRACT
Feb 2019
Assessing Bioactivity-Exposure Profiles of Fruit and Vegetable Extracts in the BioMAP Profiling System
VIEW ABSTRACT
Jan 2019
Developing Context Appropriate Toxicity Testing Approaches Using New Alternative Methods (NAMs)
VIEW ABSTRACT
Oct 2018
A Qualitative Modeling Approach for Whole Genome Prediction Using High-Throughput Toxicogenomics Data and Pathway-Based Validation
VIEW ABSTRACT
Sep 2018
An in Vitro Approach for Prioritization and Evaluation of Chemical Effects on Glucocorticoid Receptor Mediated Adipogenesis
VIEW ABSTRACT
Apr 2018
Evaluating Opportunities for Advancing the Use of Alternative Methods in Risk Assessment Through the Development of Fit-For-Purpose in Vitro Assays
VIEW ABSTRACT
Aug 2017
Multiple Receptors Shape the Estrogen Response Pathway and Are Critical Considerations for the Future of in Vitro-Based Risk Assessment Efforts
VIEW ABSTRACT
Mar 2017
Contribution of ATM and ATR Kinase Pathways to p53-mediated Response in Etoposide and Methyl Methanesulfonate Induced DNA Damage
VIEW ABSTRACT
Jan 2017
Editor's Highlight: Screening ToxCast Prioritized Chemicals for PPARG Function in a Human Adipose-Derived Stem Cell Model of Adipogenesis
VIEW ABSTRACT
Nov 2016
Editor's Highlight: Development of an In Vitro Assay Measuring Uterine-Specific Estrogenic Responses for Use in Chemical Safety Assessment
VIEW ABSTRACT
Jun 2016
Moving Beyond Prioritization Toward True In Vitro Safety Assessment
VIEW ABSTRACT
Jun 2016
Pathway Based Toxicology and Fit-for-Purpose Assays
VIEW ABSTRACT
May 2016
Approaches for Characterizing Threshold Dose-Response Relationships for DNA-damage Pathways Involved in Carcinogenicity in Vivo and Micronuclei Formation in Vitro
VIEW ABSTRACT
Mar 2016
Contributions of DNA Repair and Damage Response Pathways to the Non-Linear Genotoxic Responses of Alkylating Agents
VIEW ABSTRACT
Feb 2016
Suppression of NRF2-ARE Activity Sensitizes Chemotherapeutic Agent-Induced Cytotoxicity in Human Acute Monocytic Leukemia Cells
VIEW ABSTRACT
Oct 2015
Adaptive Posttranslational Control in Cellular Stress Response Pathways and Its Relationship to Toxicity Testing and Safety Assessment
VIEW ABSTRACT
Jun 2015
Implementing Toxicity Testing in the 21st Century (TT21C): Making Safety Decisions Using Toxicity Pathways, and Progress in a Prototype Risk Assessment
VIEW ABSTRACT
Mar 2015
Development of a Human Adipose-derived Stem Cell Model for Characterization of Chemical Modulation of Adipogenesis
VIEW ABSTRACT
Nov 2014
Profiling Dose-Dependent Activation of p53-mediated Signaling Pathways by Chemicals With Distinct Mechanisms of DNA Damage
VIEW ABSTRACT
Oct 2014
Use of Mode of Action Data to Inform a Dose-Response Assessment for Bladder Cancer Following Exposure to Inorganic Arsenic
VIEW ABSTRACT
Feb 2014
A Map of the PPARα Transcription Regulatory Network for Primary Human Hepatocytes
VIEW ABSTRACT
Feb 2014
Dose-response Modeling of Etoposide-Induced DNA Damage Response
VIEW ABSTRACT
Nov 2013
Keap1 Silencing Boosts Lipopolysaccharide-Induced Transcription of Interleukin 6 via Activation of Nuclear Factor κB in Macrophages
VIEW ABSTRACT
Sep 2013
Assessing Dose-Dependent Differences in DNA-damage, p53 Response and Genotoxicity for Quercetin and Curcumin
VIEW ABSTRACT
Sep 2013
Evaluation of a Predictive in Vitro Leydig Cell Assay for Anti-Androgenicity of Phthalate Esters in the Rat
VIEW ABSTRACT
Jun 2013
Mechanism-based Testing Strategy Using in Vitro Approaches for Identification of Thyroid Hormone Disrupting Chemicals
VIEW ABSTRACT
Jan 2013
A Dose Response Study to Assess Effects After Dietary Administration of Diisononyl Phthalate (DINP) in Gestation and Lactation on Male Rat Sexual Development
VIEW ABSTRACT
Jan 2013
Disposition of Diiosononyl Phthalate and Its Effects on Sexual Development of the Male Fetus Following Repeated Dosing in Pregnant Rats
VIEW ABSTRACT
Mar 2012
In Vitro Metabolism of Di(2-ethylhexyl) Phthalate (DEHP) by Various Tissues and Cytochrome P450s of Human and Rat
VIEW ABSTRACT
Jan 2012
Physiologically Based Pharmacokinetic/Toxicokinetic Modeling. In: Methods in Molecular Biology,
VIEW ABSTRACT
Aug 2011
Challenges in the Application of Quantitative Approaches in Risk Assessment: A Case Study With Di-(2-ethylhexyl)phthalate
VIEW ABSTRACT
Feb 2010
Assessing the Relevance of in Vitro Measures of Phthalate Inhibition of Steroidogenesis for in Vivo Response
VIEW ABSTRACT
Jun 2009
In Utero Exposure to Chloroquine Alters Sexual Development in the Male Fetal Rat
VIEW ABSTRACT
Jan 2009
Kinetics of Selected Di-N-Butyl Phthalate Metabolites and Fetal Testosterone Following Repeated and Single Administration in Pregnant Rats
VIEW ABSTRACT
Jun 2008
Tissue Exposures to Free and Glucuronidated Monobutylyphthalate in the Pregnant and Fetal Rat Following Exposure to Di-N-Butylphthalate: Evaluation With a PBPK Model
VIEW ABSTRACT
Feb 2008
Development and Specification of Physiologically Based Pharmacokinetic Models for Use in Risk Assessment
VIEW ABSTRACT
Mar 2007
Perchlorate and Radioiodide Kinetics Across Life Stages in the Human: Using PBPK Models to Predict Dosimetry and Thyroid Inhibition and Sensitive Subpopulations Based on Developmental Stage
VIEW ABSTRACT
Jan 2005
PBPK Model for Radioactive Iodide and Perchlorate Kinetics and Perchlorate-Induced Inhibition of Iodide Uptake in Humans
VIEW ABSTRACT
Feb 2004
Evidence for Competitive Inhibition of Iodide Uptake by Perchlorate and Translocation of Perchlorate Into the Thyroid
VIEW ABSTRACT
Aug 2003
Predicting Neonatal Perchlorate Dose and Inhibition of Iodide Uptake in the Rat During Lactation Using Physiologically-Based Pharmacokinetic Modeling
VIEW ABSTRACT
Jun 2003
Predicting Fetal Perchlorate Dose and Inhibition of Iodide Kinetics During Gestation: A Physiologically-Based Pharmacokinetic Analysis of Perchlorate and Iodide Kinetics in the Rat
VIEW ABSTRACT
Jun 2003
PBPK Predictions of Perchlorate Distribution and Its Effect on Thyroid Uptake of Radioiodide in the Male Rat
VIEW ABSTRACT
Jun 2002
Pharmacokinetics of Toxic Chemicals in Breast Milk: Use of PBPK Models to Predict Infant Exposure
VIEW ABSTRACT
Jun 2001
The Use of Physiologically Based Models to Integrate Diverse Data Sets and Reduce Uncertainty in the Prediction of Perchlorate and Iodide Kinetics Across Life Stages and Species
VIEW ABSTRACT
WEBSITE DESIGN BY
ADRIALDESIGNS.COM